{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:37:29Z","timestamp":1792453049167,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.ophtha.2003.12.052","type":"journal-article","created":{"date-parts":[[2004,7,2]],"date-time":"2004-07-02T12:10:16Z","timestamp":1088770216000},"page":"1275-1279","source":"Crossref","is-referenced-by-count":121,"title":["Adverse ocular drug reactions recently identified by the National Registry of Drug-Induced Ocular Side Effects"],"prefix":"10.1016","volume":"111","author":[{"given":"F.W.","family":"Fraunfelder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.T.","family":"Fraunfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2003.12.052_BIB1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0002-9394(14)72902-2","article-title":"Pamidronate disodium and possible ocular adverse drug reactions","volume":"118","author":"Macarol","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.12.052_BIB2","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJM200303203481225","article-title":"Bisphosphonates and ocular inflammation","volume":"348","author":"Fraunfelder","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2003.12.052_BIB3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0002-9394(02)01840-8","article-title":"Scleritis and other ocular side effects associated with pamidronate disodium","volume":"135","author":"Fraunfelder","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.12.052_BIB4","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1358\/dot.2003.39.11.799461","article-title":"Ocular side effects associated with bisphosphonates","volume":"39","author":"Fraunfelder","year":"2003","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.ophtha.2003.12.052_BIB5","series-title":"Drug-Induced Ocular Side Effects","year":"2001"},{"key":"10.1016\/j.ophtha.2003.12.052_BIB6","first-page":"837","article-title":"Ocular inflammation associated with alendronate therapy","volume":"117","author":"Mbekeani","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.12.052_BIB7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0002-9394(03)00869-9","article-title":"Oculogyric crisis in patients taking cetirizine","volume":"137","author":"Fraunfelder","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.12.052_BIB8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9394(01)01024-8","article-title":"Ocular side effects possibly associated with isotretinoin usage","volume":"132","author":"Fraunfelder","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.12.052_BIB9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/(SICI)1096-911X(200004)34:4<284::AID-MPO16>3.0.CO;2-D","article-title":"Pseudotumor cerebri induced by all-trans-retinoic acid in a child treated for acute promyelocytic leukemia","volume":"34","author":"Schroeter","year":"2000","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ophtha.2003.12.052_BIB10","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2169\/internalmedicine.37.546","article-title":"Pseudotumor cerebri in a patient with acute promyelocytic leukemia during treatment with all-trans-retinoic acid","volume":"37","author":"Sano","year":"1998","journal-title":"Intern Med"},{"key":"10.1016\/j.ophtha.2003.12.052_BIB11","first-page":"1420","article-title":"Pseudotumor cerebri caused by all-trans-retinoic acid","volume":"83","author":"Tiamkao","year":"2000","journal-title":"J Med Assoc Thai"},{"issue":"8356","key":"10.1016\/j.ophtha.2003.12.052_BIB12","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0140-6736(83)90495-6","article-title":"Intracranial hypertension with etretinate","volume":"2","author":"Bonnetblanc","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2003.12.052_BIB13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0190-9622(85)80367-4","article-title":"Benign intracranial hypertension during etretinate therapy for mycosis fungoides","volume":"13","author":"Viraben","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ophtha.2003.12.052_BIB14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ophtha.2003.04.004","article-title":"Topiramate-associated acute, bilateral, secondary angle-closure glaucoma","volume":"111","author":"Fraunfelder","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2003.12.052_BIB15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9394(01)01013-3","article-title":"Presumed topiramate-induced bilateral acute angle-closure glaucoma","volume":"132","author":"Banta","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.12.052_BIB16","unstructured":"U.S. Food and Drug Administration. Topamax (topiramate) tablets prescribing information. Available at: http:\/\/www.fda.gov\/medwatch\/SAFETY\/2003\/tpamax.pdf. Accessed August 10, 2003"},{"key":"10.1016\/j.ophtha.2003.12.052_BIB17","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archopht.120.8.1108","article-title":"Topiramate-associated secondary angle-closure glaucoma","volume":"120","author":"Thambi","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.12.052_BIB18","first-page":"1721","article-title":"Bilateral angle-closure glaucoma and ciliary body swelling from topiramate","volume":"119","author":"Rhee","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.12.052_BIB19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00002018-199410020-00001","article-title":"Harmonisation in pharmacovigilance","volume":"10","author":"Edwards","year":"1994","journal-title":"Drug Saf"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642004003343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642004003343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T02:53:46Z","timestamp":1549421626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642004003343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0161642004003343"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2003.12.052","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}